B-cell performance in chemotherapy: Unravelling the mystery of B-cell therapeutic potential

Zizhuo Li , Anqi Lin , Zhifei Gao , Aimin Jiang , Minying Xiong , Jiapeng Song , Zaoqu Liu , Quan Cheng , Jian Zhang , Peng Luo

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (7) : e1761

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (7) : e1761 DOI: 10.1002/ctm2.1761
REVIEW

B-cell performance in chemotherapy: Unravelling the mystery of B-cell therapeutic potential

Author information +
History +
PDF

Abstract

• Chemotherapy can inhibit B-cell proliferation and alter subset distributions and functions, including factor secretion, receptor signalling, and costimulation.

• Chemotherapy can modulate complex B-cell–T-cell interactions with variable effects on anti-tumour immunity

• Targeting B-cell surface markers or signalling improves chemotherapy responses, blocks immune evasion and inhibits tumour growth.

• Critical knowledge gaps remain regarding B-cell interactions in TME, B-cell chemoresistance mechanisms, TLS biology, heterogeneity, spatial distributions, chemotherapy drug selection and B-cell targets that future studies should address.

Keywords

anti-tumour therapy / B cells / chemotherapy / neoadjuvant chemotherapy (NACT) / targeting B cells / tumour microenvironment (TME)

Cite this article

Download citation ▾
Zizhuo Li,Anqi Lin,Zhifei Gao,Aimin Jiang,Minying Xiong,Jiapeng Song,Zaoqu Liu,Quan Cheng,Jian Zhang,Peng Luo. B-cell performance in chemotherapy: Unravelling the mystery of B-cell therapeutic potential. Clinical and Translational Medicine, 2024, 14(7): e1761 DOI:10.1002/ctm2.1761

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

124

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/